Drugs / Cranberry
Cranberry
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00200759 | Oct 2004 → Dec 2007 | — | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 23 trials · 1 met primary | ||||||
| Phase 2 | NCT05557279 | Jan 2023 → Aug 2025 | overactive bladder | Loyola University | Completed | No outcome recorded |
| Phase 2 | NCT02808013 | Jun 2016 → Sep 2017 | — | Naturex-Dbs | Unknown | No outcome recorded |
| Phase 2 | NCT01346774 | Jun 2011 → May 2013 | urinary tract infection | Betsy Foxman | Completed | Met primary |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT00280592 | Jan 2006 → Mar 2008 | multiple sclerosis, urinary bladder disorder, urinary tract infection | Rennes University Hospital | Completed | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT01881165 | Sep 2014 → Dec 2015 | urinary tract infection | University of British Columbia | Withdrawn | No outcome recorded Stop: Business |
| Phase not applicable1 trial | ||||||
| — | NCT00247104 | May 2007 → Feb 2008 | preterm premature rupture of the membranes | Hadassah Medical Organization | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT03522961 Comparator | Aug 2018 → Sep 2023 overdue | pelvic organ prolapse, urinary tract infection | Brigham and Women's Hospital | Active not recruiting | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2017-11-27 | Ache Laboratorios Farmaceuticos S.A. | Aché apresenta nutracêutico à base de extrato de cranberry ache.com.br ↗ |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cranberry | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01881165 ↗ |
| Known as | Cranberries | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00247104 ↗ |
| Known as | NDS-446 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05557279 ↗ |
| Known as | TheraCran One | “Drug: TheraCran® One Cranberry capsules” NCT03522961 ↗ |
| Known as | Vaccinium macrocarpon | “Cranberries - Vaccinium macrocarpon” NCT00247104 ↗ |
| Action | Inhibit | “Adherence of type 1 pili is inhibited by the fructose and of p pili by the proanthocyanidins present in cranberry.” NCT01346774 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Cranberries have been recognized by the American Indians as a natural means for preventing urinary tract infection.” NCT00247104 ↗ |
| Route | Oral | “Cranberry juice is administered twice a day (in the morning and in the evening).” NCT00280592 ↗ |